retatrutide trial news today Retatrutide, a new weight loss drug not available on the market yet, is showing promising results in trials. @DrLaPook explains it’s doing much more than what current medications can Phase 2 Trial of Retatrutide

And this isnt about willpower

Nichols E, Szoeke CE, Vollset SE, et al

Originally developed to treat diabetes, GLP-1 agonist medications, such as Wegovy, Ozempic, Mounjaro, and Zepbound, have evolved into one of the fastest-growing and most disruptive drug classes in modern healthcare

Once the fatty acids enter the mitochondria, they get broken down into energy

It is abundant in many human tissues, including the liver, lungs, and brain, and is central to maintaining redox balance and supporting numerous biochemical pathways

However, in response to cellular stress, Keap1 dissociates from Nrf2, allowing Nrf2 to translocate into the nucleus and activate the antioxidant response pathway [18]